Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 9/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14959294 | 1.00 | KIF11 (0.77) | KIF11MEN1KMT2ATRPV1PTGS1 | |
| SCHEMBL5422208 | 0.87 | KIF11 (1.00) | KIF11PTGS1 | |
| SCHEMBL60290 | 0.86 | KIF11 (0.63) | KIF11MEN1KMT2ATRPV1PTGS1 | |
| SCHEMBL29572624 | 0.86 | KIF11 (0.63) | KIF11MEN1KMT2ATRPV1PTGS1 | |
| SCHEMBL11095537 | 0.86 | KIF11 (0.59) | KIF11MEN1KMT2ATRPV1NTRK1 | |
| SCHEMBL19358889 | 0.84 | KIF11 (0.56) | KIF11MEN1KMT2ATRPV1NTRK1 | |
| SCHEMBL11883526 | 0.83 | KIF11 (0.55) | KIF11MEN1KMT2ATRPV1NTRK1 | |
| SCHEMBL9185909 | 0.83 | CYP1A2 (0.56) | KIF11MEN1KMT2ATSHR | |
| SCHEMBL31434967 | 0.83 | CYP1A2 (0.56) | KIF11MEN1KMT2ATSHR | |
| SCHEMBL4796235 | 0.83 | KIF11 (0.59) | KIF11MEN1KMT2APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574131-A | Heterocyclic compounds for insect repellent | 勃林格殷格翰动物保健有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-12559503-B2 | Anthelmintic aza-benzothiophene and aza-benzofuran compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| WO-2025202940-A2 | ANTIPARASITIC CYCLIC DEPSIPEPTIDES | ANIMOL DISCOVERY, INC. (US) | 2025-10-02 | — | — | WO | disclosed |
| EP-3525590-B1 | PESTICIDAL AND PARASITICIDAL VINYL ISOXAZOLINE COMPOUNDS | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-08-20 | — | — | EP | disclosed |
| US-20250243197-A1 | Anthelmintic Heterocyclic Compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-07-31 | — | — | US | disclosed |
| WO-2025149943-A1 | ANTIPARASITIC CYCLIC DEPSIPEPTIDES | ANIMOL DISCOVERY, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025120611-A1 | ANTIPARASITIC COMPOUNDS | ANIMOL DISCOVERY, INC. (US) | 2025-06-12 | — | — | WO | disclosed |
| US-12312356-B2 | Anthelmintic heterocyclic compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-05-27 | — | — | US | disclosed |
| US-12286455-B2 | Anthelmintic depsipeptide compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2025-04-29 | — | — | US | disclosed |
| US-12269822-B2 | Anthelminthic heterocyclic compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-04-08 | — | — | US | disclosed |
| US-11464763-B2 | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-10-11 | — | — | US | disclosed |
| CN-114891070-A | Anthelmintic depsipeptide compounds | 勃林格殷格翰动物保健美国公司 | 2022-08-12 | — | — | CN | disclosed |
| US-11382949-B2 | Anthelmintic depsipeptide compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-07-12 | — | — | US | disclosed |
| WO-2022140728-A1 | PARASITICIDAL COLLAR COMPRISING ISOXAZOLINE COMPOUNDS | BOEHRINGER INGELHEIM ANIMAM HEALTH USA INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| US-20220202835-A1 | INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-06-30 | — | — | US | disclosed |
| CN-114573573-A | Antiparasitic isoxazoline compounds, long-acting injectable formulations containing them, methods and uses thereof | 勃林格殷格翰动物保健美国公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-107835818-B | Anthelmintic depsipeptide compounds | 勃林格殷格翰动物保健美国公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-03-31 | — | — | US | disclosed |
| CN-109068651-B | Antiparasitic isoxazoline compounds, long-acting injectable formulations containing them, methods and uses thereof | 勃林格殷格翰动物保健美国公司 | 2022-03-01 | — | — | CN | disclosed |
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11382949-B2 | Anthelmintic depsipeptide compounds | ENPP2, ROCK2, RRP12 | KIF11 3657/4885MEN1 2930/4885KMT2A 1158/4885 |
| US-20220202835-A1 | INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF | IL5, IL17A, IL33 | KIF11 1943/4885MEN1 1718/4885KMT2A 4386/4885 |
| US-11464763-B2 | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof | EPX, P2RX7, CYP4X1 | KIF11 2863/4885MEN1 4411/4885KMT2A 2270/4885 |
| US-12312356-B2 | Anthelmintic heterocyclic compounds | AADAC, HNMT, HRH4 | KIF11 3317/4885MEN1 1548/4885KMT2A 642/4885 |
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | SDHA, PAH, PIGS | KIF11 2068/4885MEN1 2676/4885KMT2A 1440/4885 |
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | KIF11 2884/4885MEN1 1735/4885KMT2A 2523/4885 |
| US-12269822-B2 | Anthelminthic heterocyclic compounds | SDHA, PAH, PIGS | KIF11 2068/4885MEN1 2676/4885KMT2A 1440/4885 |
| US-20250243197-A1 | Anthelmintic Heterocyclic Compounds | PAH, PIGS, SDHA | KIF11 2212/4885MEN1 1888/4885KMT2A 1729/4885 |
| US-12559503-B2 | Anthelmintic aza-benzothiophene and aza-benzofuran compounds | HDAC5, NR5A2, HRH4 | KIF11 2701/4885MEN1 3843/4885KMT2A 820/4885 |
| US-12286455-B2 | Anthelmintic depsipeptide compounds | VIP, PREP, DNPEP | KIF11 3126/4885MEN1 1902/4885KMT2A 2407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.